Brought to you by:
![Vascular Specialist [LIVE]](https://vascularspecialistonline.com/wp-content/uploads/2026/08/vascular_specialist_logo_forwebsite_new.png){kind=logo}
SVS mourns death of Past President Kenneth Wayne Johnston
The Society for Vascular Surgery (SVS) mourns the death of Kenneth Wayne Johnston, an SVS member, former president and recipient in 2009 of the SVS’ highest honor, the Lifetime Achievement Award. Barry Rubin, MD, chair and program medical director for…
Novel drug candidate for slowing AAA growth demonstrates safety in humans
The local delivery of a glucose-derived compound in small- and medium-sized abdominal aortic aneurysms (AAAs) has been deemed safe, with “promising” early efficacy data indicating its potential in stabilising or slowing AAA sac growth. According to Stephen Cheng, MBBS, MS,…
BEST-CLI investigators implore a move beyond endo vs. open ‘battle’ in the name of scientific advance
The principal investigators behind the BEST-CLI trial struck a conciliatory tone during the inaugural Frank J. Veith Distinguished Lecture yesterday morning in which they laid bare the blood, sweat and tears shed on their journey to complete the landmark study.…
Special VAM session underscores ‘complementary’ nature of open and endovascular strategies in CLTI patients
A dedicated session at VAM 2023 saw speakers and delegates gather to debate, analyse and consider the implementation of the BEST-CLI and BASIL-2 randomized-controlled trials (RCTs). There was general agreement that the strategies are complementary, and that “picking the right…
Crawford panel focuses minds on challenges facing vascular surgery workforce numbers
Yesterday’s E. Stanley Crawford Critical Issues Forum, which looked at ways to address the pipeline of sources feeding the vascular surgery pool of talent, yielded an illuminating perspective on the looming workforce crisis currently occupying leaders in the field. Speaking…
More research needed but lithotripsy plus TCAR ‘an answer’ in certain carotid disease patients
Earlier this year, researchers debuted single-center experiences indicating that intravascular lithotripsy (IVL) may be able to expand transcarotid artery revascularization (TCAR) into patients with traditionally prohibitive calcific disease. With a multicenter case series now further suggesting IVL’s utility, but also…
The essential ‘need’ for vascular surgeons in pulmonary embolism treatment paradigm
The specter of pulmonary embolism (PE) as a common and lethal disease process—with mortality of massive PE static at about 50% for decades while rapid advances were made in stroke and STEMI care—forms the backdrop to a VAM 2023 breakfast…
VQI@VAM: Social media helps promote safe technique, study finds
A social media campaign promoting educational videos proved efficient and cost-effective, and similar campaigns will be useful for quality improvement projects directed toward medical trainees. That’s the message from “A social media campaign to promote safe technique in femoral access,”…
‘Nobody believed us’: Vascular giant discusses overcoming skeptics to make specialty-defining breakthroughs
Malachi Sheahan III, MD, Vascular Specialist’s medical editor, speaks to living legend and limb-salvage pioneer Frank J. Veith, MD, on the contents of his hard-hitting new book, The Medical Jungle: A Pioneering Surgeon’s Battle to Revolutionize Vascular Care and Challenge…
BASIL-2 and BEST-CLI: A tale of two limb trials
Optimal treatment of patients with chronic limb-threatening ischemia (CLTI) has been an ongoing debate within the vascular community, fueled by growing numbers of patients, evolving technologies, provider bias, and a lack of high-quality evidence. Few randomized controlled trials (RCTs) have…